
Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA, but aren't seeking EUA yet
CNN
Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.
A formal submission to request EUA for the vaccine is expected to follow in the coming weeks, the companies said in a statement.
Submissions to the European Medicines Agency and other regulatory authorities are also planned, they said.

Websites for Harvard College centers serving minority students, LGBTQ students and women vanished on Wednesday, according to reporting by The Harvard Crimson, marking the continued unraveling of diversity initiatives at the nation’s most prestigious university as it faces continued pressure from the Trump administration.